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tensive (HTN) patients. Methods: The study included adults (18 yrs. or older) 
HTN patients covered by commercial and Medicare Supplemental insurance in the 
Truven MarketScan database with an HTN diagnosis between October 2009 and 
December 2011. At least two filled prescriptions for Exforge HCT or two periods 
of minimum 15 days of concurrent use of amlodipine, valsartan and hydrochlo-
rothiazide (FC cohort) were required. Patients were continuously enrolled at least 
12 months before and 12 month after the index prescription and had valsartan 
initial dose of 160 or 320 mg/day. Adherence was measured with proportion of days 
covered (PDC) and medication possession ratio (MPR). Persistence was defined as 
no treatment gap greater than 30 days. Chi-Square tests and independent sample 
t-tests were used after adequate propensity score matching (PSM) (absolute stand-
ardized differences < 0.1) using demographics, comorbidities, pre-index health 
care utilization , pre-index costs and valsartan initial dose. Results: Exforge 
HCT patients (N= 9,221) had better unadjusted outcomes compared to FC patients 
(N= 1,884): higher MPR (81.6% vs 77.0%), PDC (70.0% vs 60.6%) and persistence 
(42.7% vs 23.6%) (all p< 0.0001). After risk-adjustment with PSM, Exforge HCT 
patients also exhibited better outcomes compared to FC patients: higher adher-
ence (85.7% vs 77.0%), higher PDC (73.8% vs 60.6%) and persistence (46.8% vs 23.6%) 
(all p< 0.0001). More patients had MPR> 80% in the Exforge HCT cohort (72.9% vs 
57.5%, p< 0.0001). ConClusions: Real-world data indicate that Exforge HCT is 
associated with improved adherence and persistence compared to amlodipine/
valsartan/hydrochlorothiazide FC. These data should be considered by stakehold-
ers engaged with optimizing outcomes of HTN patients.
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objeCtives: Diet and exercise along with the pharmacological treatment are 
required for an adequate control of blood pressure among hypertensive patients. 
The aim of this study is to identify the drug treatments prescribed and attitudes 
and factors associated with the adherence to these indications. Methods: Socio-
demographic and drug treatment information of hypertensive patients aged 20 years 
and older was obtained from an institutional health survey, Encoprevenimss 2010. 
Statistical relationships between socio-demographic variables and adherence to diet 
and exercise were tested. Two binary logistic regression models were constructed to 
measure the impact of personal attitudes and social and demographic variables on 
the decision of the patient whether to follow these recommendations. Results: 
Captopril was the leading prescribed drug (31.63%), followed by enalapril (22.45%) 
and metopropol (13.58%). The main combination of drugs recommended was cap-
topril with metopropol. Additionally to the pharmacological treatment, 32.47% and 
23.59% of the patients reported full adherence to the diet and exercise indications 
respectively, 24.04% and 15.78% partially complied and 11.03% and 16.63% did not 
comply. At 5% level of significance, statistically significant relationships were found 
between diet and exercise with gender (p-vale= 0.007, p-value= 0.000), as well as 
with age groups (p-value= 0.000). The results from the logistic regressions show 
that patients with lack of interest about the importance of diet and exercise in 
their treatment are less likely to adhere to these recommendations. Furthermore 
individuals that have their blood pressure monthly monitored compared with those 
who make it annually, are two times more likely to comply with diet and 1.25 times 
with exercise. Patients at a higher level of education and at older ages have a greater 
probability to follow these indications. ConClusions: Health campaigns and pro-
grams to encourage patients to monitor frequently their blood pressure are desirable 
in order to improve compliance to non-pharmacological suggestions.
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the AssoCiAtion of ADherenCe AnD heAlth BehAViors With heAlth 
stAtus Among PAtients With hyPertension in JAPAn
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objeCtives: Patients with hypertension in Japan report poor health outcomes, 
particularly quality of life. Although quality of life can be improved with advances 
in treatment, there are other modifiable factors which could also be examined 
as potential targets for intervention. This study investigated the association of 
medication adherence and health behaviors with health status. Methods: Data 
from the Japan 2012 National Health and Wellness Survey (NHWS) were used 
(N= 30,000). Only respondents taking a medication for their hypertension were 
included (n= 3,611). Smoking status, exercise behavior, obesity (measured using 
body mass index), alcohol use, and medication adherence (measured using the 
Morisky Medication Adherence Scale [MMAS-8]) were used as predictors of health 
status (measured using the Short Form-36v2) controlling for demographics and 
comorbidities. Results: A total of 67.2% respondents were male; the mean age 
was 63.11 years. Most patients had a history of smoking (19.6% were current smok-
ers and 36.7% were former smokers) and nearly 30% consumed alcohol daily. On 
average, patients exercised less than 7 days per month and a third of patients were 
either overweight (27.6%) or obese (5.8%). When examining items of the MMAS-8, 
forgetfulness was the most common reason for non-adherence (forgetting, 47.8%; 
difficulty remembering, 28.9%; forgetting when traveling/leaving home, 20.7%). 
Controlling for demographics and comorbidities, the strongest predictors of health 
status were with obesity (b = -2.68 for PCS), exercise (b = 0.14 for PCS), and forget-
ting medications (-1.08 for PCS) (all p< .05). ConClusions: Significant associations 
between adherence and health behaviors and health status were observed. Although 
cross-sectional associations may not translate to causal relationships, these results 
suggest that improved exercise and weight reduction may result in notable health 
status improvements, aside from their well-known clinical benefits. Interventions 
which make it easier for patients to remember their medications could also have 
health status benefits.
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objeCtives: Dyslipidemia has been associated with decrements in health sta-
tus among patients in Japan. Aside from improved treatment regimens, health 
behavior and adherence interventions may also help to improve patient outcomes. 
This study investigated the association of adherence and health behaviors with 
health status among patients with dyslipidemia in Japan. Methods: Data from 
the Japan 2012 National Health and Wellness Survey (NHWS) were used (N= 30,000). 
Only respondents who were using a prescription medication for dyslipidemia 
were included (n= 1,510). Smoking, exercise behavior, obesity (measured using 
body mass index), alcohol use, and medication adherence (measured using the 
Morisky Medication Adherence Scale-8) were self-reported by the patient and used 
as predictors of health status (measured using the physical component summary 
[PCS] and mental component summary of the Short Form-36v2) controlling for 
demographics and comorbidities. Results: The respondents had a mean age of 
61.4 years; slightly more than half (53.2%) were male. Most patients had a his-
tory of smoking (18.6% were current smokers and 33.9% were former smokers) 
and patients exercised a mean of 7.1 days per month. Nearly 30% of patients 
were either overweight (23.9%) or obese (5.0%). Intentional non-adherence was 
high with 52.50% of patients cutting back or stopping their medication on their 
own. Forgetfulness was also common (forgetting, 35.7%; not taking medication in 
the past two weeks, 25.9%; difficulty remembering, 18.3%). Controlling for demo-
graphics and comorbidities, the strongest predictors of health status were with 
smoking (b = -1.04 for PCS), obesity (b = -3.51 for PCS), exercise (b = 0.14 for PCS), 
and forgetting medications (b = -0.75 for PCS) (p< .05). ConClusions: Smoking 
cessation, improved exercise, and weight reduction may all result in significant 
health status improvements among patients with dyslipidemia. Interventions 
which make it easier for patients to remember their medications could have health 
status benefits in this population.
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objeCtives: The prevalence of the clustering of cardiometabolic risk factors 
(CMSRFs) namely hypertension, obesity, hyperlipidemia and diabetes is increasing. 
But there is limited recent information on prevalence, demographic characteris-
tics, quality of life and health care expenditures. Methods: Full year consoli-
dated data of the nationally representative Medical Expenditure Panel Survey 
was used (2009-2010). Many similar clinical conditions coded by the International 
Classification of Diseases (ICD-9-CM) diagnostic code are assimilated together to 
form Clinical Classification Categories (CCC). CCCs were used to identify patients 
with hyperlipidemia and hypertension whereas the interview component was 
used to identify patients with obesity and diabetes. CMS patients were defined 
as patients diagnosed with obesity and any two conditions among hypertension, 
hyperlipidemia and obesity. Prevalence of CMS, quality of life, workdays missed 
and total health care expenditures were determined among patients. Results: 
The prevalence of CMS was found to be 0.92% with the weighted frequency of 
CMS resulting to 2,848,683. Among the quality of life variables, most CMS patients 
reported having little interest in things ‘all the time’ (61.6%). They felt calm (47.1%), 
faced difficulty climbing stairs (35.6%) and walking steps (30%) and experienced 
pain (30%) ‘most of the times’. They ‘sometimes’ faced health limitations (40%), 
had lot of energy (33.7%) and accomplished less due to physical problems (25.5%). 
Most accomplished less (41%), had work limitations ‘none of the time’ (30.3%) 
and faced difficulty standing ‘little of the times’ (33.7%). 37.8% rated their SF-12 
evaluated general health as fair. The total number of workdays missed reported 
by CMS patients were ~3.5 times as compared to patients without CMS (5.12 vs 
1.42). The weighted mean total health care expenditures for CMS patients was 
$5128 vs $492 for those without CMS. ConClusions: The prevalence of CMSRFs 
is increasing alarmingly. They have a detrimental effect on quality of life, work 
productivity and health care expenditures.
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Cheng W.H., Rash C., Patel P., Gratie D., Bathija S., Pickard A.S., Berbaum M., Hellenbart E., 
McDowell M., Khan M., Shapiro N., Galanter W., Stamos T., Nutescu E.
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objeCtives: The aims of this study were to compare patient outcomes associ-
ated with TSOAC and warfarin in terms of quality of life (QoL). Methods: We 
conducted a prospective, cross-sectional cohort study in an inner-city population 
treated with warfarin or a TSOAC for more than 3 months. The Duke Anticoagulation 
and Satisfaction Scale (DASS) was used to assess the anticoagulation-related QoL. 
Multivariate linear regression analysis was conducted to evaluate the association 
between TSOAC and QoL, adjusted for potential confounders. Results: A total 
of 138 consecutive patients were enrolled in the study, 73 in the warfarin group 
and 65 in the TSOAC group. Patients treated with a TSOAC were older (63.2±16.1 
vs. 54.9±16, p= 0.002), more likely to be white (33.9% vs.6.9%, p< 0.001), had higher 
education level (4 year college degree or higher, 34.4% vs. 9.6%, p= 0.004), and higher 
annual income (> $30,000, 75.7% vs 35%, p< 0.001), compared with warfarin treated 
patients. Patients treated with TSOAC, reported lower rates of bleeding or throm-
boembolism leading to emergency department visits or hospitalizations during 
the preceding twelve months of therapy, compared with warfarin treated patients 
(13.9% vs. 32.9%, p= 0.01). However, patients on TSOAC reported a higher rate of side 
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effects other than bleeding and thrombosis (38.5% vs. 16.7%, p= 0.004). Patients on 
TSOAC had a lower [better] mean QoL summary score compared to warfarin treated 
patients (39.2±11.3 vs. 46.8±19.8, p= 0.01). Based on the results of the unadjusted lin-
ear regression model, patients treated with TSOAC had significantly better DASS QoL 
summary score (β = -7.65, 95% CI: -13.49, -1.82, p < 0.05); however, after adjusting for 
differences in patient groups, the effect of TSOAC on QoL became non-significant (β = 
4.47, 95% CI: -5.06, 14.00, p= 0.35) ConClusions: Differences in social-demographic 
characteristics between patients treated with warfarin and TSOAC were observed 
in an inner-city population. After adjusting for patient social-demographic charac-
teristics, TSOAC had no impact on treatment-related QoL.
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objeCtives: SDQ-PBS was a validated and reliable diagnostic instrument 
for syndrome of PBS of angina patients. For well reception and wide applica-
tion, it was important and necessary to verify the diagnostic accuracy of the 
syndrome dimension of the questionnaire before applications. Methods: 
The Fisher’s discriminant model was established for syndrome of PBS dimen-
sion to determine weights of items. Angina patients (40-85 years old) diagnosed 
by coronary angiography or coronary computed tomography were selected to 
complete the SDQ-PBS. Syndrome of PBS and non-PBS (any other syndromes) 
were diagnosed by 3 traditional Chinese medicine physicians. According to the 
Canadian Cardiovascular Society Classification (CCSC), subjects of PBS were 
divided into mild and severe degree. Final scores were calculated combining 
initial scores and weights of items. The diagnostic accuracy was preliminarily 
verified by comparison of final scores and diagnostic threshold. Results: 
The Fisher’s discriminant model = 1.444× somber complexion+1.083× heavy 
body+0.913× purple lips+0.845× poor appetite+0.605× glomus and full-
ness+0.436× sliminess in mouth–6.426. There were 44 subjects (age: 69.12±9.26, 
sex: male,36.36%) involved and 35 were diagnosed PBS, 9 non-PBS. According to 
CCSC, 19 were mild degree and 16 severe. Through the comparison of final scores 
and diagnostic threshold (8.5), 34 of 35 PBS subjects were diagnosed as syndrome 
of PBS, the diagnostic accuracy of the syndrome dimension was 97.143%. Of 9 
non-PBS subjects, 1 was diagnosed PBS, the diagnostic accuracy was 88.889%. For 
subjects of mild and severe degree, 18 and 16 were diagnosed PBS respectively, 
the diagnostic accuracy were 94.737% and 100%. ConClusions: The diagnostic 
accuracy of the syndrome dimension of the questionnaire was high. For different 
degree of angina, the instrument was more suitable for severe patients. In the 
future, more study will be conducted to further verify the diagnostic accuracy of 
the questionnaire.
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A systemAtiC reVieW, CritiCAl APPrAisAl AnD AnAlysis of the QuAlity 
of eConomiC eVAluAtions in stroke imAging
Burton K.R.1, Perlis N.1, Krahn M.2, Kapral M.K.2, Moody A.1, Laupacis A.2
1University of Toronto, Toronto, ON, Canada, 2Toronto, ON, Canada
objeCtives: To review the quality of economic evaluations of acute stroke imag-
ing to direct thrombolytic therapy and to identify areas for improvement in future 
economic evaluations. Methods: We conducted searches of electronic data-
bases including Medline, EMBASE, CINAHL, Econlit, the NHS Economic Evaluation 
Database and the Tufts Cost-Effectiveness Analysis (CEA) Registry from January 
1950 through July 2012. Inclusion criteria were empirical studies published in any 
language that reported economic evaluation results of two or more imaging inter-
ventions for patients presenting with symptoms suggestive of acute stroke. Study 
quality was assessed by a 35-item checklist published by the British Medical Journal 
(BMJ). Results: A total of 1,063 citations were identified, and 5 met the inclusion 
criteria. Four of 5 papers were explicit in their analysis perspectives, which included 
health care system payers, hospital and other stroke service providers. Two stud-
ies reported results for 5-year time horizons and 3 reported lifetime results. All 
reported morbidity outcomes using the modified Rankin Scale score. The median 
quality score using the BMJ tool was 84.4% (range = 71.9-93.5%). Three studies evalu-
ated perfusion computed tomography (CTP) as a comparator to unenhanced CT 
(UCT) but due to a paucity of data, assumed that CTP outcomes were equivalent 
to those of patients assessed by other imaging modalities. Most studies included 
post-thrombolysis intracranial hemorrhage states but most did not take into con-
sideration the effects of AIS patients who could not tolerate contrast media or who 
incurred contrast-induced nephropathy (CIN). ConClusions: Economic evalua-
tions in acute stroke imaging are of high quality with respect to published methodo-
logical guidelines. Economic analyses of imaging in AIS patients may benefit from 
the inclusion of important clinical components of AIS imaging modeling including 
the incidence of CIN and recurrent stroke in addition to the incorporation of CTP-
specific outcome data.
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fACtors influenCing mAnAgement of PAtients With AtriAl 
fiBrillAtion in CAnADA AnD sWeDen
Lara N.1, Evers T.2, Levac B.3, Fraschke A.4, Pedrós M.1
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objeCtives: To explore the reasons for not initiating or stopping VKA treatment 
in patients with atrial fibrillation (AF) at moderate to high risk of stroke, along 
with the reasons for considering some patients on VKA to be “difficult-to-man-
age”. Methods: A retrospective chart review was conducted with 39 Canadian and 
29 Swedish physicians participating. Three cohorts of AF patients at moderate/high 
stroke risk (CHADS2score ≥ 2 points) were examined: a) VKA naïve, b) had stopped 
VKA treatment or c) receiving VKA and considered “difficult-to-manage”. Variables 
retrieved were: sociodemographic data and comorbidities, variables related with AF 
and its management and the reasons why patients a) never received VKA, b) stopped 
VKA, or c) were considered “difficult-to-manage”. Results: In Canada, 187 patients 
were included (naïve/stopped/difficult-to-manage 62/42/83), 58.3% males, mean (SD) 
age 78.4 (8.9) years. In Sweden, 152 patients were included (naïve/stopped/difficult-
to-manage 39/24/89), 68.4% males, mean (SD) age 76.0 (8.8) years. For VKA naïve 
patients, the most common reasons for not initiating VKAs were: Canada – transient 
nature of AF (40.3%), fall risk (30.6%); Sweden - patient refusal to take VKAs (28.2%), 
fall risk (1.8%), bleeding risk (1.8%). For patients who stopped VKA treatment, the 
most common reasons for discontinuation were: Canada – bleeding event (23.8%), 
patient unable to comply with therapy/monitoring (19.0%); Sweden – bleeding event 
(45.8%), clinical event (18.2%). For patients on VKA the most common reasons for 
being considered “difficult-to-manage” were: Canada – concomitant chronic dis-
eases (55.4%), poor INR control (54.2%); Sweden – difficulties in following dietary/
behaviour advice (24.7%), concomitant chronic diseases (22.5%). ConClusions: In 
Canada and Sweden the reasons for not initiating or stopping VKA treatment in AF 
patients were similar, with fall risk and bleeding events being commonly cited. The 
main reasons for considering a patient on VKA as “difficult-to-manage” are mainly 
related to concomitant diseases in both countries.
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PhysiologiCAl PArAmeters CAn helP guiDe heArt fAilure therAPy
Emmanuel J., Rathod K., Pittaway J., Mannan I., Mastan A.
Royal London Hospital, London, UK
objeCtives: Heart failure leads to significant morbidity and mortality. New phar-
maco-therapeutic interventions based on the patients heart rate have been incor-
porated into treatment algorithms, and may lead to improved clinical outomes. 
We set out to assess the reliability of physiological assessments made at the bed 
side in the abscence of BNP measurements. We also set out to assess adherence 
to new heart failure pharmacotherapeutic algorithm at our hospital, and to iden-
tify the prevalence of atrial fibrilation, and other aetiology in patients presenting 
with heart failure. Methods: Most patients with chronic heart failure are man-
aged in the community by nurse specialist and general practitioners. Patients with 
decompensated acute heart failure usualy present to secondary and tertiary care. 
We undertook an audit to identify all patients presenting with heart failure over a 
10 week period in a London Teaching Hospital (n= 54). Results: The average age 
was 76.6±10.5, there were 30 males, 31 patients were of caucasian descent and 
21 from ethnic minority, 2 patients were not categorised. There was a significant 
decline in heart rate (p= 0.0013), systolic pressure (p= 0.0128) and diastolic pressure 
(p= 0.0254) from admission. Patients with heart failure utilised significantly more 
bed days per admission than other cardiology admissions (10.34±1.3 against other 
cardiolgy- 8.78). Atrial fibrillation was a contributory factor in 16 patients. Ischaemic 
heart disease was noted in 21 patients, valvular heart disease was only noted in 
6 patients. The therapeutic algorithm was not adhered to in most patients. The 
new therapy Ivabradine was under utilised, despite featuring in the algorithm. The 
breakdown of pharmacotherapy on admission: Furosemide (n= 31), beta-blockade 
(n= 26), ACE inhibitors and receptor blockers (n= 26), Aldosterone receptor blockers 
(n= 8), Calcium channel antagonist (n= 9), Nitrates= 10. ConClusions: Physiological 
parameters are useful in guiding therapeutic intervention. The new agents are 
under-utilised, and this may be due to a lack of understanding of their long term 
benefits in saved bed days. Therapies that promote a faster heart rate should be 
utilised with caution.
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PersonAl CArDioVAsCulAr heAlth risk Assessment AnD mAnAgement 
in the Work PlACe: A Pilot ProgrAm
Yen JMC1, LU I.C.1, Yen S.E.S.2, Chien H.C.1
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objeCtives: To set up a model for effective workplace health management 
as an occupational health service for employees of a steel factory in southern 
Taiwan. Methods: In compliance with the administrative regulation of the com-
pany’s policy, 53 male employees with persistent blood pressure (BP) higher than 
160/100 mmHg, and 23 male employees with persistent fasting blood sugar (FS) 
higher than 200 mg/dl during the last three consecutive annual employee health 
examination were identified through a process of cardiovascular risk assessment, 
and recruited into a health management program, which consisted of health edu-
cation for diet control and regular exercise, mandatory weekly BP or postprandial 
blood sugar (PC) monitoring at company medical office for 3 months, and subject 
was required to submit proof of physician visit and drug treatment if the subject 
was noted to have BP higher than 140/90 mmHg or PC higher than 200 mg/dl in two 
consecutive measurements. Outcome evaluation was analyzed with descriptive 
statistics. Results: At the end of the program, the mean systolic BP among the 53 
hypertensive subjects decreased from 161 mmHg to 145 mmHg, diastolic BP from 
104 mmHg to 94 mmHg, and 7 of them achieved satisfactory BP control under 120/80 
mmHg. The mean PC among the 23 diabetic subjects decreased from 297 mg/dl to 
240 mg/dl, and 5 of them achieved satisfactory PC control under 140mg/dl. Out of 
the 46 subjects who filled out the program satisfaction survey, 97.8% were satisfied 
with the dietary control component of the health education course, 93.5% were 
satisfied with the exercise component, 97.8% were satisfied with weekly BP or PC 
measurements, and 58.7% would recommend the same program to their colleagues 
in the future. ConClusions: Company management policy is a key element in the 
success of workplace health management for the control of chronic diseases with 
high cardiovascular risk such as hypertension and diabetes.
